Thrombin Human

Thrombin Human

Thrombin Human Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

EVITHROM®, Thrombin, Topical (Human), is indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical.

EVITHROM, Thrombin, Topical (Human), may be used in conjunction with an Absorbable Gelatin Sponge, USP.

History

There is currently no drug history available for this drug.

Other Information

EVITHROM is provided as a sterile powder of purified human thrombin.The lyophilized powder is white to slightly yellowish in color. When reconstituted, EVITHROM solution, pH 6.8-7.2, is clear to slightly opalescent and colorless to slightly yellowish in color.

The composition of the lyophilized powder of EVITHROM is as follows:

Active Ingredients:

Human thrombin (1600-2400 units)

Other Ingredients:

Calcium chloride, Human albumin, Mannitol, Sodium acetate

EVITHROM is made from pooled Human Source and Recovered Plasma obtained from US licensed plasma collection centers. Individual plasma units obtained for production of EVITHROM are tested by licensed serological tests for HBsAg, HIV 1 & 2 Ab and HCV Ab and recovered plasma units are also tested for HTLV I/II. Additionally, the plasma units are tested by licensed Nucleic Acid Testing (NAT) for HIV-1, HCV, HBV, HAV and parvovirus 19. All tests for HIV, HCV, HBV and HAV must be negative (non-reactive). However, since the effectiveness of the HBV and HAV NAT methods in detecting low levels of viral material is still under investigation, the significance of a negative result for these viruses is unknown. The level of parvovirus B19 contamination is not permitted to exceed 10,000 copies/ml. This limit is applied to restrict the viral load of parvovirus B19 in the starting plasma pool. In addition to the screening of plasma units, each manufacturing pool is tested for HBsAg, HIV-1 & 2 Ab, and for HCV NAT. Manufacturing pool testing, however, is of lower sensitivity than individual unit testing.

EVITHROM is manufactured by chromatographic purification of prothrombin from cryo-poor plasma followed by activation with calcium chloride. The manufacturing process includes two targeted steps for inactivation or removal of viruses. The first of these is treatment with a solvent/detergent (S/D) mixture (1% tri-n-butyl phosphate, 1% Triton X-100) for 6 hours at 26°C to inactivate lipid enveloped viruses. The S/D reagents are removed by cation exchange chromatography. Mannitol and human albumin are used to stabilize the solution, which undergoes nanofiltration for removal of both enveloped and non-enveloped viruses. After nanofiltration, the solution is formulated with calcium chloride, sterile filtered and aseptically filled and frozen.

The effectiveness of the S/D treatment and nanofiltration procedures for reducing virus content has been assessed using a series of viruses with a range of physico-chemical characteristics. The results of the validation studies are summarized in Table 2.

Table 2: Reducing factors of S/D treatment and nanofiltration for a series of viruses
Virus HIV-1 SBV BVDV PRV EMCV HAV CPV
Reduction factor (log10)

HIV-1: Human Immunodeficiency Virus Type 1

SBV: Sindbis Virus

BVDV: Bovine Viral Diarrhea Virus

PRV: Pseudorabies Virus

EMCV: Encephalomyocarditis virus

HAV: Hepatitis A Virus

CPV: Canine Parvovirus

SD Treatment >5.82 >5.31 >4.74 >4.25 Not Done Not Done 0.0
Nanofiltration >4.36 >5.32 Not Done >5.47 6.37 6.95 5.85
Global Reduction Factor >10.18 >10.63 >4.74 >9.72
6.37
6.95 5.85

Thrombin Human Manufacturers


  • Ethicon, Inc
    Thrombin Human Powder, For Solution [Ethicon, Inc]

Login To Your Free Account